T-cell study gains insight into COVID-19 immunity, asymptomatic people could be safer
LONDON: A small UK study has found that “cellular immunity” to the pandemic SARS-CoV-2 virus is present after six months in people who had mild or asymptomatic COVID-19 infections – suggesting they might have…
Covid-19: DCGI Rejects Dr Reddy’s Proposal Seeking Full Marketing Authorisation of Remdesivir
India’s central drug regulator has rejected Dr Reddy’s Laboratories’ application seeking approval for full marketing authorisation of anti-viral drug remdesivir which has so far been allowed restricted emergency use on…
Dr Reddys hopes to finish Phase 3 trials of Covid-19 vaccine by March-May
Dr Reddys Laboratories on Wednesday said the Phase 3 trials of Russia’s Sputnik V vaccine for Covid-19 in India to be conducted by it are expected to be completed by the end of March…
Antibodies detectable up to 7 months after Covid infection, number depends on severity of disease
LONDON: Antibodies against the novel coronavirus follow a classic pattern with a rapid increase within the first three weeks after symptoms, and detectable up to seven months post contracting the disease, according to…
WHO chief warns against ‘vaccine nationalism’
Berlin: The head of the World Health Organization (WHO) on Sunday called for global solidarity in the rollout of any future coronavirus vaccine, as the number of cases soared across the world. In a…
Surgical, N-95 Masks Can Reduce Covid-19 Cough-Cloud By 7, 23 Times: IIT-Bombay Study
Mumbai : Surgical and N-95 masks can reduce the volume of a coronavirus disease (Covid-19)–laden cough-cloud by seven and 23 times, respectively, according to a recent study conducted by two scientists…
Covid : India’s active cases below 7 lakh after 21-day decline
New Delhi : India’s active Covid cases went below the 7-lakh mark on Thursday as the downtrend continued for the 21st day running, with the number of discharged patients outstripping fresh…
Anti-parasitic drug ivermectin not to be included for Covid-19 treatment protocol: Health Ministry
New Delhi: The Union Health Ministry has decided not to include ivermectin medicine (anti-parasitic drug) in the National Clinical Management Protocol for Covid-19 for the treatment of virus-infected patients. The move comes after the Central government’s…
Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments
One of the world’s biggest trials of COVID-19 therapies released its long-awaited interim results yesterday—and they’re a letdown. None of the four treatments in the Solidarity trial, which enrolled more…